FIELD: medicine.
SUBSTANCE: inventions relate to medicine, namely to dermatology and represents application of formula I compounds: R-O-R1 (I), were R represents linear or branched alkyl residue, which contains 5-8 carbon atoms, and R1 represents formal group or acetyl group.
EFFECT: invention ensures improvement of permeability of one or more therapeutic active substances, when using in product, intended for local nail care, which can contain physiologically compatible auxiliary substances.
10 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STEROID ESTERS OR THEIR STEREOISOMERS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2112775C1 |
| 22R- OR 22S-EPIMERS OF COMPOUNDS, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION, AND METHOD OF TREATING ALLERGIC AND INFLAMMATORY DISEASES | 1992 |
|
RU2111212C1 |
| 16α,17a-ACETAL-SUBSTITUTED ANDROSTANE-17b-CARBOXYLIC ACID ESTERS OR THEIR STEREOISOMERS | 1991 |
|
RU2081879C1 |
| DERIVATIVES OF ANDROSTENE, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2194053C2 |
| METHOD FOR PREPARING FLUMETASONE, COMPOUND | 2002 |
|
RU2260596C1 |
| SPECIFIC GLYCOCOTRICOSTEROID COMPOUND WITH ANTIINFLAMMATORY EFFECT | 2004 |
|
RU2348645C2 |
| COMPOSITION FOR PER OS TREATING INFLAMMATORY GASTROENTERIC TRACT DISEASES | 1990 |
|
RU2134104C1 |
| 11β-ACYLOXY-17α- HYDROPEROXY-16α- METHYLPREGNANES SHOWING LOCAL ANTIINFLAMMATORY ACTIVITY | 1991 |
|
RU2030421C1 |
| PREGNANE DERIVATIVES SUBSTITUTED IN 17-POSITION, METHOD OF THEIR SYNTHESIS, INDUSTRIAL PRODUCTS, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2177951C2 |
| APPLICATION OF H, K-ATPase INHIBITOR FOR TREATING NASAL POLYPS | 1997 |
|
RU2197966C2 |
